- Home
- AUTL vs ONT Comparison
AUTL vs ONT Comparison
Compare AUTL & ONT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AUTL | ONT |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United Kingdom | United States |
| Employees | N/A | 3500 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 596.2M | 643.7M |
| IPO Year | 2025 | 2020 |
Fundamental Metrics
Financial Performance| Metric | AUTL | ONT |
|---|---|---|
| Price | $1.89 | $17.04 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 440.2K |
| Earning Date | 05-14-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 93.69 |
| EPS | N/A | ★ N/A |
| Revenue | $10,120,000.00 | ★ $830,538,000.00 |
| Revenue This Year | $80.32 | N/A |
| Revenue Next Year | $53.96 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 496.00 | 19.26 |
| 52 Week Low | $1.18 | $12.68 |
| 52 Week High | $2.58 | $23.32 |
Technical Indicators
Market Signals| Indicator | AUTL | ONT |
|---|---|---|
| Relative Strength Index (RSI) | 40.65 | 46.39 |
| Support Level | $1.84 | $14.39 |
| Resistance Level | $1.92 | $18.70 |
| Average True Range (ATR) | 0.09 | 0.89 |
| MACD | -0.02 | -0.07 |
| Stochastic Oscillator | 8.89 | 36.01 |
Price Performance
Historical ComparisonAbout AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Company's T cell programming technologies tailors therapies to address the specific disease targeting and introduce new programming modules into a patient's T cells to give those T cells improved properties to recognize target cells and overcome fundamental disease defense mechanisms.
About ONT Onterris Inc. Common Stock
Onterris Inc is an environmental solutions company. The company provides environmental solutions to organizations addressing regulatory, operational, and environmental challenges. Its services include the application of scientific, engineering, and data-driven approaches to support risk management, compliance, and environmental protection, including air, water, and soil.